Your Location：
Home >
Browse articles >
Mechanism of Mingshi Prescription in Regulating Opn4-dopamine Axis to Inhibit Endoplasmic Reticulum Stress and Delay Myopia Progression
Updated：2025-08-21
Previous|Next

    • Mechanism of Mingshi Prescription in Regulating Opn4-dopamine Axis to Inhibit Endoplasmic Reticulum Stress and Delay Myopia Progression

    • “The latest research has found that Mingshi Fang effectively delays the growth of the myopic eye axis by regulating the melanin dopamine axis to inhibit endoplasmic reticulum stress.”
    • LI Baohua , KANG Zefeng , WANG Lulu , YAN Xin , WANG Jianquan , HOU Xinyue , NING Bobiao , YE Shanshan , LIU Mengyu , SHI Yipeng , LI Danyu
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 18, Pages: 58-67(2025)

    • DOI： 10.13422/j.cnki.syfjx.20251422     

      CLC：

    • Revised：2025-05-16 ，

      Accepted：20 June 2025 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 5 ) Tabs( 7 )

  • References

  • Publication Info

  • Metrics

386

Views

341

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Xianglian Huazhuo Prescription Regulates GP73/PERK/ATF4 Signaling Pathway to Influence Endoplasmic Reticulum Stress and Ameliorate Chronic Atrophic Gastritis
Hezhong Xiaopi Granules Regulate Ncln-CHOP Axis to Inhibit Endoplasmic Reticulum Stress and Reduce Gastric Mucosal Cell Apoptosis
Traditional Chinese Medicine Modulates Endoplasmic Reticulum Stress for Prevention and Treatment of Neuropathic Pain： A Review
Mechanism of Shengjiang Pingchuan Zhike Pills in Improving Bronchial Asthma via Regulating Apoptosis Mediated by Endoplasmic Reticulum Stress Based on GRP78/ATF6/CHOP Signaling Pathway
Discussion on Modern Development of Traditional Chinese Medicine Diagnosis Based on Artificial Intelligence

Related Author

DU Pengli
GUO Yuxi
WANG Yican
JIN Ziqi
KANG Xin
JIA Xuemei
XU Weichao
CAI Yanru

Related Institution

Graduate School， Hebei University of Chinese Medicine
The First Affiliated Hospital of Hebei University of Chinese Medicine
Hebei Provincial Key Laboratory of Turbid Toxin Syndrome
Postdoctoral Research Center， China Academy of Chinese Medical Sciences
Guang'anmen Hospital， China Academy of Chinese Medical Sciences